BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10364343)

  • 21. Infection of human cells by murine ecotropic viruses: retroviral vectors carrying the hygromycin resistance-encoding gene.
    Suzuki H; Brown GD; Ohno K; Meruelo D
    Gene; 1996 May; 170(2):255-9. PubMed ID: 8666255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a replication-competent retrovirus resulting from recombination of packaging and vector sequences.
    Otto E; Jones-Trower A; Vanin EF; Stambaugh K; Mueller SN; Anderson WF; McGarrity GJ
    Hum Gene Ther; 1994 May; 5(5):567-75. PubMed ID: 8054374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simian immunodeficiency virus vectors: replication and pseudotyping.
    Rizvi TA; Panganiban AT
    J Med Primatol; 1992; 21(2-3):69-73. PubMed ID: 1433269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells.
    Robbins PB; Yu XJ; Skelton DM; Pepper KA; Wasserman RM; Zhu L; Kohn DB
    J Virol; 1997 Dec; 71(12):9466-74. PubMed ID: 9371608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retroviral vectors for high-level transgene expression in T lymphocytes.
    Engels B; Cam H; Schüler T; Indraccolo S; Gladow M; Baum C; Blankenstein T; Uckert W
    Hum Gene Ther; 2003 Aug; 14(12):1155-68. PubMed ID: 12908967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel integrating adenoviral/retroviral hybrid vector for gene therapy.
    Murphy SJ; Chong H; Bell S; Diaz RM; Vile RG
    Hum Gene Ther; 2002 Apr; 13(6):745-60. PubMed ID: 11936973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variables controlling the expression level of exogenous genes in Dictyostelium.
    Pang KM; Lynes MA; Knecht DA
    Plasmid; 1999 May; 41(3):187-97. PubMed ID: 10366524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T cell-specific expression from Mo-MLV retroviral vectors containing a CD4 mini-promoter/enhancer.
    Zhao-Emonet JC; Marodon G; Pioche-Durieu C; Cosset FL; Klatzmann D
    J Gene Med; 2000; 2(6):416-25. PubMed ID: 11199262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High rate of genetic rearrangement during replication of a Moloney murine leukemia virus-based vector.
    Varela-Echavarría A; Prorock CM; Ron Y; Dougherty JP
    J Virol; 1993 Nov; 67(11):6357-64. PubMed ID: 7692080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homologous recombination occurs in a distinct retroviral subpopulation and exhibits high negative interference.
    Hu WS; Bowman EH; Delviks KA; Pathak VK
    J Virol; 1997 Aug; 71(8):6028-36. PubMed ID: 9223494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A small and efficient dimerization/packaging signal of rat VL30 RNA and its use in murine leukemia virus-VL30-derived vectors for gene transfer.
    Torrent C; Gabus C; Darlix JL
    J Virol; 1994 Feb; 68(2):661-7. PubMed ID: 8289369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid generation and flow cytometric analysis of stable GFP-expressing cells.
    Lybarger L; Dempsey D; Franek KJ; Chervenak R
    Cytometry; 1996 Nov; 25(3):211-20. PubMed ID: 8914818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of recombinatory PCR to insert subtle genetic markers into Moloney murine leukemia virus-based retroviral vectors.
    Skinner CR; Jones JS
    J Virol Methods; 2000 Mar; 85(1-2):125-36. PubMed ID: 10716346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new family of murine retroviral vectors with extended multiple cloning sites for gene insertion.
    Faustinella F; Kwon H; Serrano F; Belmont JW; Caskey CT; Aguilar-Cordova E
    Hum Gene Ther; 1994 Mar; 5(3):307-12. PubMed ID: 8018745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methods for constructing and producing retroviral vectors.
    Gambotto A; Kim SH; Kim S; Robbins PD
    Methods Mol Biol; 2000; 135():495-508. PubMed ID: 10791344
    [No Abstract]   [Full Text] [Related]  

  • 36. Genetic rearrangements occurring during a single cycle of murine leukemia virus vector replication: characterization and implications.
    Parthasarathi S; Varela-Echavarría A; Ron Y; Preston BD; Dougherty JP
    J Virol; 1995 Dec; 69(12):7991-8000. PubMed ID: 7494312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New genetic tools for use in the Rhizobiaceae and other bacteria.
    Barnett MJ; Oke V; Long SR
    Biotechniques; 2000 Aug; 29(2):240-2, 244-5. PubMed ID: 10948423
    [No Abstract]   [Full Text] [Related]  

  • 38. Enhanced transgene expression in primitive hematopoietic progenitor cells and embryonic stem cells efficiently transduced by optimized retroviral hybrid vectors.
    Ketteler R; Glaser S; Sandra O; Martens UM; Klingmüller U
    Gene Ther; 2002 Apr; 9(8):477-87. PubMed ID: 11948372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy.
    Junker U; Böhnlein E; Veres G
    Gene Ther; 1995 Nov; 2(9):639-46. PubMed ID: 8548553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging cells in the developing nervous system with retrovirus expressing modified green fluorescent protein.
    Okada A; Lansford R; Weimann JM; Fraser SE; McConnell SK
    Exp Neurol; 1999 Apr; 156(2):394-406. PubMed ID: 10328944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.